Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2024
Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repairElisa Pezzola, Daniela Tomasoni, Berenice Caneiro-Queija, et al.
International Journal of Cardiology|August 27, 2022
Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohortMaribel González-Del-Hoyo, Oriol Rodríguez-Leor, Ana Belén Cid-Álvarez, et al.
Contemporary Clinical Trials Communications|September 29, 2020
Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and designIván J Núñez-Gil, Vicente Estrada, Cristina Fernández-Pérez, et al.
Revista Portuguesa De Cardiologia|April 3, 2018
Effect of beta-blocker dose on mortality after acute coronary syndromeSergio Raposeiras-Roubin, Emad Abu-Assi, Berenice Caneiro-Queija, et al.
Journal of Clinical Medicine|March 25, 2022
Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary SyndromeClara Bonanad, Sergio Raposeiras-Roubin, Sergio García-Blas, et al.
The American Journal of Cardiology|August 16, 2023
Takotsubo Syndrome, Stressful Triggers, and Risk of RecurrenceClara Fernández-Cordón, Iván Javier Núñez-Gil, Irene Martín de Miguel, et al.
Thrombosis Journal|March 22, 2023
Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort studyAlbert Ariza-Solé, Gemma Mateus-Porta, Francesc Formiga, et al.
Journal of Clinical Medicine|October 13, 2021
Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary SyndromePablo Díez-Villanueva, Jose María García-Acuña, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 13, 2022
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre studyGiuseppe Patti, Fabrizio D'Ascenzo, Ovidio De Filippo, et al.
Lancet (London, England)|January 17, 2021
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasetsFabrizio D'Ascenzo, Ovidio De Filippo, Guglielmo Gallone, et al.
Pageof 10